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Abstract: Background: Ischemia and ischemia-reperfusion (I/R) are common clinical insults that disrupt the molecular 
structure of coronary vascular endothelial luminal membrane (VELM) that result in diverse microvasculature dysfunc-
tions. However, the knowledge of the associated biochemical changes is meager. We hypothesized that ischemia and  
I/R-induced structural and functional VELM alterations result from biochemical changes. First, these changes need to be 
described and later the mechanisms behind be identified.  
Methods: During control conditions, in isolated perfused rat hearts VELM proteins were labeled with biotin. The groups 
of hearts were: control (C), no flow ischemia (I; 25 min), and I/R (I; 25 min, reperfusion 30 min). The biotinylated  
luminal endothelial membrane proteins in these three different groups were examined by 2-D electrophoresis and   
identified. But, it must be kept in mind the proteins were biotin-labeled during control.  
Results: A comparative analysis of the protein profiles under the 3 conditions following 2D gel electrophoresis showed 
differences in the molecular weight distribution such that MWC > MWI > MWI/R. Similar analysis for isoelectric points 
(pHi) showed a shift toward more acidic pHi under ischemic conditions. Of 100 % proteins identified during control 66% 
and 88% changed their MW-pHi during ischemia and I/R respectively. Among these lost proteins there were 9 proteins 
identified as adhesins and G-protein coupled receptors.  
General significance: I and I/R insults alter MW-pHi of most luminal glycocalyx proteins due to the activation of non-
specific hydrolizing mechanisms; suspect metalloproteases and glycanases. This makes necessary the identification of  
hydrolyzing enzymes reponsible of multiple microvascular dysfunctions in order to maintain the integrity of vascular  
endothelial membrane. VELM must become a target of future therapeutics. 
Keywords: Luminal endothelial membrane, G-protein coupled receptors, Adhesins, Metalloproteases, Glycanases, Luminal  
endothelial solutes exclusion zone.  
1. INTRODUCTION 
  Clinically myocardial ischemia and ischemia/reperfusion 
(I/R) insults; a scientific and a major clinical problem [1], 
indiscriminatingly occur during cardiac transplant, coronary 
bypass, angioplasties, thrombolysis, open heart surgery and 
all interventions that result in transient interruption of an 
organ circulation. All these beneficial procedures have 
brought relieve to millions of patients, but, the associated I/R 
insult causes diverse cardiac dysfunctions whose mecha-
nisms, by not being well understood prevent correct treat-
ments. I/R injure different cell types and their organelles [2-8]. 
However, the coronary vascular endothelial luminal   
membrane (VELM) despite its role on infarct size [10, 12, 13], 
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it is suspect I/R induce important chemical structural 
changes and as compared to these changes in other organ-
elles [2-5, 8, 9], VELM changes are unknown. 
  VELM or ”luminal endothelial glycocalyx”, is a molecu-
lar complex composed of a large variety of extracellular do-
mains of transmembrane proteins, glycoproteins, proteogly-
cans, glycosaminoglycans and matrix bound plasma proteins 
[13-16], consequently in the VELM reside multiple normal 
and pathological functions; solute wall permeation, flow 
sensing, hormone reception, coagulation, atherosclerosis etc 
[7,12,13,17-19, 21-23]. All these endothelial luminal func-
tions are disturbed by ischemia and I/R and associated oxy-
gen radicals [1, 20, 24]. The luminal endothelial glycocalyx 
has a thickness estimated between 0.2 - 0.8 μm [11-14, 18, 
20]. In living microcirculatory preparations in which fluores-
cently labeled dextran of various sizes (50 to 2,000 kD) were 
infused intraarterially. Fluorescence distributed uniformly in 
most of the lumen of blood vessels, but was absent in a zone 240    The Open Cardiovascular Medicine Journal, 2011, Volume 5  Arroyo-Flores et al. 
0.2 – 0.8 μm thick adjacent to the vessel wall, an “endothe-
lial exclusion zone” (EEZ). Infusion of dextrans of lower 
molecular weight resulted in a deeper penetration implying 
that EEZ constitutes a barrier for solute difussion likely   
the result of a restricted diffusion through densely packed 
molecules [18, 20, 24-26]. 
  Conditions that lead to a EEZ decrease, a deeper solute 
diffusion through the VELM, can be acheived by treatment 
with oligosaccharide hydrolyzing enzymes, hyaluronidase 
[20, 24, 25] and heparinase [27], and by treatment with in-
flammatory stimuli such as oxidized low-density lipoproteins 
[28],
 TNF- [26] and oxidative stress [20]. EEZ decrease is 
the early step in the inflammatory cascade associated with 
I/R injury that results in endothelial dysfunction [10, 12, 13, 
17, 24]. Thus, diverse stimuli can alter the VELM structure 
as a result of a still undescribed change in chemical composi-
tion. We hypothesized that ischemia and I/R-induced struc-
tural and functional VELM alterations result from biochemi-
cal changes that firstly need to be described, later identify the 
mechanisms behind. This strategy will lead to successful 
medical treatments. 
  To isolate with high purity coronary VELM proteins we 
adopted a novel strategy; in situ VELM protein biotinylation 
[29]. Experiments were performed in retrogradely perfused 
isolated rat hearts. Selectively Biotin-labeled coronary 
VELM proteins from myocardial tissue homogenates were 
purified and identified. The biotin-labeled coronary VELM 
proteins were identified either by two-dimensional gel elec-
trophoresis followed by Western blot or by passing the tissue 
membrane fraction through a Streptavidin-Biotin affinity 
chromatography column. We found that ischemia and I/R 
stimuli produced alterations of most coronary VELM protein 
molecular weight (MW) and their isoelectric point profiles, 
but I/R insult caused the more drastic changes.  
2. MATERIALS AND METHODS (FOR DETAILS SEE 
SUPPLEMENTAL MATERIAL) 
  Hearts were removed and coronaries retrogradely per-
fused [22, 23]. Thereafter, VELM proteins were selectively 
labeled by intracoronary perfusion of biotin during control 
conditions. After biotin labeling period, hearts were perfused 
with buffer and processed for immunohistochemical identifi-
cation of biotin in tissue sections (brown color).  
  In three groups of hearts coronary VELM was biotin la-
beled during control period, thereafter biotin exccess was 
wash off with PBS. One group of hearts was inmediately 
processed for tissue protein extraction (control group), a 
secong group was subjected to 25 min of ischemia and tissue 
protein extracted (ischemia group) and the third group was 
subjected to 25 min ischemia, followed by a 30 min reperfu-
sion period (I/R group), thereafter processed for tissue   
protein extraction. Tissues were homogenized and whole 
tissue cardiac membranes (CM) were isolated, divided into 2 
aliquots to identify coronary VELM proteins, one aliquot 
was processed for SDS-2D gel electrophoresis and Western 
blot [30] to identify biotin-labeled VELM proteins (proce-
dure No 1). The second CM aliquot was applied to mono-
meric avidin affinity column and bound biotinylated proteins 
were eluted with D-biotin in PBS; VELM fraction (proce-
dure No 2). The SDS-2D gel results obtained with both pro-
cedures were the same.  
  On control coronary VELM protein fraction dot Immuno-
blots were performed, dots were incubated with a primary 
antibody, follow by a secondary antibody coupled to HRP 
rinsed and DAB was used to develop HRP color reaction. 
Twelve specific antigens were identified.  
3. RESULTS 
3.1. Biotinylation of Coronary Vascular Endothelial 
Membrane Proteins 
  The heart tissue sections were examined by inmunohisto-
chemical microscopy to verify if biotin was confined to the 
vascular endothelium. The perfused heart was well preserved 
morphologically (Fig. 1A, control) and when revealed with 
DAB intense staining was restricted to the endothelium of all 
blood vessels, with prominent capillary labeling (Fig 1B and 
1C). This indicates the vascular bed was well perfused and 
most of the vascular endothelial membrane was biotinylated. 
3.2. SDS-PAGE Protein Profile Ladders 
  Two equal aliquots of CM proteins were loaded on two 
separate SDS-PAGE gels and run. Thereafter, one gel was 
stained with Sypro Ruby (CM, Fig. 1D) and the other gel 
was blotted to nitrocellulose membrane and developed for 
biotin (VELM, Fig. 1E). Fig. (1D) show different protein 
profiles, the CM proteins of control (C), and the two injury 
conditions, ischemia (I) and I/R heart (IR). The CM protein 
ladder profiles from control and ischemic hearts show differ-
ences that became more striking in the I/R fraction, with 
increased number of low molecular weight bands. The bio-
tin-labeled VELM protein profile ladders are shown in Fig. 
(1E). As in the case of Fig. (1D), protein ladder profiles of 
I/R hearts show striking differences in the number of low 
molecular weight bands compared to control.  
3.3. CM Western Blot Biotin Analysis 
  To determine in coronary VELM proteins the individual 
changes induced by ischemia and I/R, the CM proteins sub-
jected to 2D SDS-PAGE were electro-transferred to nitrocel-
lulose membranes and developed with HRP-streptavidin-
DAB (Fig. 2). Individual protein profile distributions of 
coronary VELM differences between individual protein be-
tween control (Fig. 2A) and ischemia (Fig. 2B) are notice-
able, but more striking differences appear in I/R group (Fig. 
2C). These data show that ischemia and I/R injuries affect 
MW and pHi of many individual coronary VELM proteins of 
the rat heart. 
  By dot blot, the following 12 proteins were identified in 
the VELM protein fraction: the hormone receptors for 
adenosine A1 and A2A, thromboxane A2 (TXA2), endothelin 
ETA, adrenergic 1 and 1, Angiotensin AT1, prolactin PRL, 
and bradykinin B2, the channel EnaC and the adhesive pro-
teins PECAM-1, VCAM-1 and ICAM-1. All these VELM 
proteins gave a positive dot blot reaction (Fig. 3). Of this list 
for 1, 1, AT1, PRL, B2, EnaC, PECAM-1, VCAM-1, and 
ICAM-1 their corresponding molecular weigths (MW) and 
isoelectric points (pHi) have been reported. Protein points Proteolysis of Coronary Luminal Membrane by Ischemia and I/R  The Open Cardiovascular Medicine Journal, 2011, Volume 5    241 
with these coordinates were identified in the control biotin-
2D-SDS-PAGE results (Fig. 2A).  
3.4. Comparison of Protein Profile Distributions from 
Western Blot Biotin Analysis Studies 
  To compare quantitatively and directly the differences   
in coronary VELM bi-dimensional MW-pHi distributions 
between control, ischemia and ischemia-reperfusion, the 
coordinates (MW, pHi) of each protein-point was determined 
and the values plotted as shown in Fig. (4). Keep in mind 
that all proteins identified via  biotin, were labeled during 
control not during ischemia nor I/R. 
3.4.1. Comparison between Control and Ischemia Graphs 
  The 2 upper figures correspond to control (Fig. 4A)  
and ischemia (Fig. 4B). In the control graph (Fig. 4A) all 
points (circles and dots) are 58 protein-points present during 
control condition. The dots are coordinates reported for the 9 
identified proteins (Fig. 4A) mentioned above. In ischemia 
graph (Fig. 4B) all protein-points (triangles and half filled 
triangles) present during ischemia are shown. Triangles are 
protein-points with different coordinates that are not present 
during control; i. e control proteins whose MW and pHi were 
chanced by ischemia. But, half filled triangles (20 protein-
points) are protein-points that have the same coordinates as 
protein-points in the control, likely ischemia resistant pro-
teins. These results show that only 20/58 protein-points (34 
%) remain unchanged, while 66 % of the protein-points their 
MW and pHi were altered by ischemia. None of the dots in 
(Fig.  4A) appear in (Fig. 4B) indicating the coordinates 
(MW and pHi) of 1, 1, AT1, PRL, B2, EnaC, PECAM-1, 
VCAM-1, and ICAM-1 were changed by ischemia. Clearly, 
transition from control to ischemia results in alteration of the 
MW and pHi of 66 % of protein-points (ischemia susceptible 
proteins), while a smaller fraction of protein-points their 
 
Fig. (1). Histological tissue sections: A) non-biotin labeled heart; 
control. B) and C) biotin perfused heart. Biotinylation; brown color, 
is restricted to the coronary vascular endothelium. All capillaries 
were labeled by the biotin (arrows). D) Electrophoretic patterns   
of CM protein fraction during control (C), I and I/R. E) Electro- 
phoretic patterns of biotinylated coronary VELM. CM protein   
fractions from SDS-PAGE were transferred to nitrocellulose   
membranes and coronary VELM proteins revealed by DAB. I/R 
patterns (E) display more bands of low molecular weight proteins 
compared to C.   
Fig. (2). 2D-SDS Western blotting patterns of biotinylated coronary 
VELM proteins during control (A), Ischemia (B) and I/R (C). 
VELM proteins were biotin labeled during control conditions. No-
tice that from A to B to C there is an increase in the number of low 
molecular weight spots. 242    The Open Cardiovascular Medicine Journal, 2011, Volume 5  Arroyo-Flores et al. 
coordinates remain unchanged (half filled triangles), likely 
ischemia resistant proteins. 
 
Fig. (3). By immuno-dot blot ten G-coupled hormone receptors and 
three adhesins proteins were identified in the coronary VELM protein 
fraction. The arrows indicate proteins whose MW-pHi coordinates are 
known and in the plot (MW-pHi) in figure 4A were identified. 
3.4.2. Comparison between Ischemia and I/R Graphs 
  The 2 lower figures correspond to ischemia (Fig. 4C=4B) 
and I/R (Fig. 4D). In the left graph (Fig. 4C) all protein-
points (triangles and half-filled squares) were present during 
ischemia. In the right graph (Fig. 4D) all proteins-points 
(squares and half filled squares) were present during I/R. 
Transition from ischemia to I/R shows that triangles protein-
points (Fig. 4C) are not present in I/R; I/R susceptible pro-
teins, while half-filled squares (Figs. 4C and 4D) are 9 pro-
tein-points whose MW and pHi were not chanced by I/R; I/R 
resistant protein-points. These results show that 9/38 protein-
points (23 %) coordinates during ischemia remain un-
changed, while 76% of the protein-points their MW and pHi 
were altered by I/R. I/R cause the appearance of a larger 
number of biotin-labeld low MW proteins with new coordi-
nates (squares). Here again, transition from ischemia to I/R 
results in alteration of the coordinates of 76% of protein-
points (I/R susceptible proteins), while small number of pro-
tein-points their coordinates remain unchanged; likely IR 
resistant proteins. Of the 9 protein-points; I/R resistant pro-
teins, 7 are protein-points found during control conditions. 
This implies that only 7/58 protein-points (12 %) in control 
are ischemia and I/R resistant proteins and the rest 88% their 
MW and pHi are altered, indicating that likely non-specific 
hydrolizing mechanisms are activated by ischemia and I/R. 
 
Fig. (4). Graphical representation of Molecular weights (abscissae) and Isoelectric pH (ordinates) of biotin-labled VELM proteins. Control coroanry 
VELM proteins (A), ischemia VELM proteins (B and C) and ischemia/reperfusion VELM proteins (D). Comparison between A and B: (A) all 
points (circles and half filled triangles, 58 protein-points) show the proteins identified in control. Dots are proteins whose coordinates (MW, pHi) 
are known and correspond to: 1, 1, AT1, PRL, B2, EnaC, PECAM-1, VCAM-1, and ICAM-1. (B). All points (triangles and half filled trian-
gles) show the proteins identified in ischemia. Half filled triangles are 20 protein-points that were not affected by the transition from control to 
ischemia. None of the dots in A appear in B. Comparison between C (=B) and D: (C) all points (Triangles and half filled squares show all the 
proteins identified in ischemia. Triangle points are proteins that do not appear during ischemia/reperfusion in D. (D) all points (squares and half-
filled squares) show the proteins identified in ischemia/reperfusion. Half filled squares are 9 protein-points that were not affected by the transition 
from ischemia to ischemia/reperfusion. Of these 9 protein-points, 7 also appear in control A, i. e. are proteins resistant to ischemia and I/R. Proteolysis of Coronary Luminal Membrane by Ischemia and I/R  The Open Cardiovascular Medicine Journal, 2011, Volume 5    243 
3.4.3. MW and pHi Populations Distribution Plots of   
Coronary Protein Points During Control, Ischemia and I/R 
  Since each of the transitions from control to ischemia and 
from ischemia to I/R are associated with obvious MW-pHi 
coordinate changes, we decided to analyze the data via MW 
(Fig.  5A) and pHi (Fig. 5B) population distribution plots. 
The left graph shows that during control conditions (trian-
gles) coronary VELM proteins have a MW range between 
100kDa to 20kDa with the largest proportion of proteins 
having a MW of about 80kDa and only 13% with a MW less 
than 60kDa. Ischemic VELM proteins (squares) also have a 
MW range between 100kDa to 20kDa with the largest pro-
portion of proteins having a MW of about 40kDa and 43% 
with a MW less than 60 kDa i. e. there is a shift in the distri-
bution curve to the left with fewer number of high MW pro-
teins and more low MW proteins. The changes induced by 
ischemia are further amplified by I/R. Under this condition 
(filled squares) the MW range is also between 100kDa to 
20kDa with the largest number of proteins having a MW of 
about 40kDa and there is a further shift of the distribution 
curve to the left with 51% of proteins having a MW less than 
60kDa. 
  With respect to the pHi protein population distribution 
plots (Fig. 4B), the majority of proteins from control hearts 
possess pHi in the 6-6.5 range which shifts to more acidic 
pHi following ischemia. Reperfusion leads to a shift in pHi 
distribution towards control conditions. 
4. DISCUSSION 
  Our results show that coronary VELM proteins, “the lu-
minal endothelial glycocalyx” proteins biotin-labeled during 
control conditions show drastic chemical changes during the 
successive stages of ischemia and I/R. 
  Our results of MW population distribution analyses show 
that a shift toward lower MW proteins with ischemia was 
further accentuated by I/R. These 2 insults also affected the 
pHi population distribution (control peak pHi = 6.5), ische-
mia displaced the group toward a more acidic pH (peak   
pHi = 6.0) and I/R shifted to pI = 6.3 (Fig. 5B).  
  In the present work, the biotin coronary VELM protein 
labeling method by Zhou et al., [29] was modified to be   
certain that during infusion, the biotin-reactive agent (S-
NHS-LC-biotin) was confined to the coronary intravascular 
space so that only VELM proteins were labeled (Fig. 1). This 
was achieved by adjusting 2 parameters, the intravascular 
concentration of the labeling agent was diluted 16 times 
(from 2 mg/ml to 0.125 mg/ml) to reduce its concentration 
gradient and the period of S-NHS-LC-biotin perfusion was 
shortened from 120 to 5 sec to reduce 24 times the diffusion 
period, followed by a 55 sec wash period (6 cycles). In our 
hands using the conditions of Zhow et al., [33] resulted in 
intense labeling of all cell membranes of coronary vascular; 
endothelial and smooth muscle cells and the cardiac cells 
membranes (not shown). It is possible that these differences 
with Zhow et al., work may reside in differences between the 
vasculature of the 2 tissues. Our methodology detects only 
those proteins that were labeled during control conditions. 
Any biotin-labeled proteins identified during ischemia or I/R 
are to proteins labeled during control except that their MW 
and pHi were changed by those insults. Our procedures   
provide information about protein biochemical history from 
control to ischemia and from ischemia to I/R.  
4.1. Possible Activating Mechanisms of the Alteration of  
Coronary VELM Protein Profiles; An Open Question 
 MW  and  pHi alterations of VELM population distribu-
tions induced by ischemia and I/R imply that control proteins 
with each successive transition: control to ischemia (66%) 
and to I/R (88%), suffer partial hydrolysis either of their pro-
teic (both MW and pHi changes) or/and their oligosaccharide 
moieties (only MW changes). This widespread hydrolysis 
include a list of G-protein couple receptors and adhesive 
proteins (Fig. 3), indicates that hormonal activation of these 
VELM G-coupled receptors and adhesive proteins is altered. 
Evidence supports the activation by ischemia and I/R of both 
 
Fig. (5). Population distributions of Molecular weight (A) and isoelectric pH (B) of coronary VELM proteins during control, ischemia and 
ischemia/reperfusion. (A).The greatest number of proteins for control was 80kD, for ischemia and ischemia/reperfusion the peaks were at 
40kD. The control curve for MW > 60kD lies above that for ischemia and even lower is the ischemia/reperfusion curve. In contrast, the con-
trol curve for MW < 60kD lies below that for ischemia and even lower than the ischemia/reperfusion curve. (B). The control, ischemia and 
ischemia/reperfusion pHi curves also differ. The greatest number of proteins for control have a pI = 6.40, for ischemia and ische-
mia/reperfusion the corresponding peaks were at pI = 6.0 and pI = 6.2 respectively. 
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proteic and glycan hydrolyzing mechanisms [10, 20, 26, 31-
36]. But, the mechanisms of the activation by these insults 
are only suspect. 
  Endothelial proteic shedding has been linked to metallo-
proteinase (MMP) activation and their activation by schemia 
and I/R in heart is well documented [10, 31-36]. Specifically, 
MMP activity has been shown to increase following reperfu-
sion and may be responsible for glycocalyx shedding and 
cleveage of the 2-adrenergic receptor [32, 33]. But, the 
mechanism of MMP activation is not clear. 
  In contrast to protease activation by ischemia and I/R, 
activation of glycosaminoglyclans-hydrolyzing mechanisms 
have been inferred. Luminal endothelial glycocalyx   
thickness/EEZ thickness” is reduced in size if heparinase   
and hyaluronidase [20, 25, 27] are infused. In addition, if 
hyaluronidate (which competes for hydrolysis with the   
endogenous hyaluronidate) is infused prior to I/R, the   
EEZ thickness is not affected [20]. The activation of other 
types of glycanases by ischemia and I/R is suggested when 
exogenous lectins upon binding to protein oligosaccharides 
moieties protect these sites (prevent EEZ reduction) from 
hydrolysis by I/R activated glycanases [24]. We have   
recently shown that the level of total glycosaminoglycans  
of coronary VELM is decreased by ischemia and I/R [36], 
but the glycanases involved were not identified. Evidence 
indicates that TNF-, cytokines and reactive oxygen species 
play an important role in I/R injury [1, 10, 20, 26, 31-35, 37]. 
They may be the activating agents of protein and oligosac-
charide hydrolyzing enzymes in control VELM seem to be 
dormant.  
4.2. Possible Functional Implications of the Changes of 
Coronary VELM Properties Induced by Ischemia and I/R 
  In proteins of the coronary VELM reside multiple func-
tions; solute permeability, hormone reception, flow sensing, 
inflammation, atherosclerosis, coagulation etc, [7, 12, 13, 17-
19, 21-23]. These functions likely are altered from control   
to ischemia and to I/R because coronary VELM protein   
MW and pHi profiles between control, ischemia and I/R are 
different. 
  Solute endothelial permeabilty is determined by the 
chemical properties and thickness of EEZ. EEZ thickness 
suffers important reduction in size during I/R and the   
associated change in chemical composition (Figs. 3, 4) imply 
there must be important selective permeability changes   
[20, 26]. 
  The coronary VELM is an important site of hormone 
reception [6, 23, 33] and flow sensing [22] a list of G-protein 
coupled receptors and EnaC a flow sensor, reside in   
this structure as shown above. Here we show that these 
estructures are cleave because their MW-pHi coordinates   
are altered by ischemia and by I/R, implying that the phar-
macology and flow sensing function of VELM are also   
altered. VELM proteins like PECAM-1, V-CAM-1 and I-
CAM-1 associated with inflammatory and coagulation proc-
esses [17, 24] their chemistry (MW and pHi) is also altered 
by ischemia and I/R so must be their function 
  Much remains unclear about the mechanisms involved in 
I/R injury. Furthermore, our data are consistent with the idea 
that a large modification of the glycocalyx chemistry and 
structure are important steps in the pathological cascade of 
events leading to I/R injury and infarct size. This indicates 
that modification of the glycocalyx is a primary component 
of early I/R effects and should be a therapeutic target in the 
prevention and/or treatment of I/R injury [1]. 
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